Biliary Disease in Immunocompromised Patients: A Single Center Retrospective Analysis

Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report

“…Unfortunately Overall, the development of gangrenous cholecystitis highlights the complications that can arise during systemic immunosuppressive treatment for IgG4-RD. A known feature in immunosuppressed patients is acalculous cholecystitis, which is acute inflammation of the gallbladder wall in the absence of gallstones [49] and gangrene of the gallbladder occurs in about 60% of patients with acute acalculous cholecystitis [50]. These data give rise to the assumption that immunosuppression may have favored the development of gangrenous cholecystitis in our patient.…”